Why is P & G Health Ltd falling/rising?

As of 20-Aug, Procter & Gamble Health Ltd is experiencing a decline in its stock price, currently at Rs 6,279.00, which reflects a decrease of Rs 26.5 or 0.42%. The stock has traded in a narrow range of Rs 45.1 today and is currently 3.36% away from its 52-week high of Rs 6,490. Despite this decline, the stock has shown positive performance over the past month, with a return of 6.92%, and a year-to-date increase of 20.06%. The company has demonstrated high management efficiency with a return on equity (ROE) of 32.32% and has maintained a low debt-to-equity ratio. However, there are concerns regarding poor long-term growth, as net sales have only grown at an annual rate of 7.39% over the last five years, which may be contributing to the stock's current downward movement.
In the broader market context, while the stock has outperformed the benchmark Sensex in the past year with a return of 15.88% compared to the Sensex's 1.31%, it is important to note that the stock's recent performance is not in line with the benchmark's short-term return of 1.32% over the past week, where the Sensex has outperformed it at 1.64%. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 32.3% against the five-day average, indicating a potential decrease in market interest. This combination of factors, including strong institutional holdings and recent positive quarterly results, contrasts with the concerns about long-term growth, creating a complex picture for investors.